10-Hydroxycamptothecin
Next-Generation Anticancer Agent for Pharmaceutical and Research Applications

Key Benefits

Potent Anticancer Agent: 10-Hydroxycamptothecin is a highly active derivative of Camptothecin, inhibiting topoisomerase I and leading to DNA damage, apoptosis, and cell cycle arrest in cancer cells.

Enhanced Therapeutic Activity: Known for its stronger anticancer potency compared to its parent compound, making it an ideal candidate for cancer drug development and treatment.

Naturally Derived: Extracted from the Camptotheca acuminata tree, a plant used in traditional medicine, ensuring the natural origin of this bioactive compound.

Promising for Drug Development: Utilized in creating novel cancer therapies, especially in the development of next-generation chemotherapy agents targeting various cancers like ovarian, colon, and lung cancers.

Scientific and Clinical Recognition: Widely studied in pharmaceutical research and clinical trials for its potential to treat a range of malignancies, with promising results in early-stage treatments.

Applications

Cancer Research: Investigated for its ability to inhibit topoisomerase I, making it a key molecule in the search for more effective cancer treatments.

Oncology Drug Development: Used as a precursor in the synthesis of potent anticancer drugs for chemotherapy protocols.

Pharmaceutical Manufacturing: Ideal for the production of cancer treatments, offering a foundation for drug formulations and novel therapeutic approaches.

Clinical Trials: Emerging as a promising candidate in clinical trials for its ability to combat aggressive cancers with fewer side effects.

Biomedical Research: Utilized in the study of cell cycle regulation, apoptosis, and DNA repair mechanisms in cancer cells.